Good feedback from the curves on slide 7.
Important to see that expansion of the cohort by 20% has not changed the average wound size at each time point by much. Implies that the data variability is not large, hence greater chance of hitting a p-value.
The more I see from this very well designed trial, the more I like.
Good feedback from the curves on slide 7. Important to see that...
Add DLM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.227M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| DLM (ASX) Chart |
Day chart unavailable